Recalls / Generics / Norepinephrine Bitartrate
Norepinephrine Bitartrate
4 FDA drug recalls involving generic “Norepinephrine Bitartrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-01-23 | Class II | Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 2 | Baxter Healthcare Corporation |
| 2023-03-29 | Class III | Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDC 47335-615-4 | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2017-08-22 | Class II | Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop | Pfizer Inc. |
| 2017-05-18 | Class II | Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, | Hospira Inc., A Pfizer Company |